Abdominal Fat, Not the Scale, Emerging as Stronger Indicator of Cancer Risk

Researchers say hidden visceral fat may drive inflammation and tumor growth even in people with normal BMI.

Published on Feb. 22, 2026

Got story updates? Submit your updates here. ›

A growing body of research suggests that measuring waist size may provide more meaningful insight into cancer risk than relying solely on overall body weight or body mass index (BMI). Experts increasingly point to visceral fat — the deep abdominal fat that surrounds internal organs — as a more dangerous predictor of disease, as it releases pro-inflammatory compounds that contribute to chronic inflammation and cancer development.

Why it matters

While obesity has long been linked to elevated cancer rates, visceral fat, which behaves like an endocrine organ, may be a more accurate indicator of cancer risk. This hidden fat can promote inflammation, insulin resistance, and abnormal cell growth even in individuals with a normal BMI.

The details

Visceral fat lies deep within the abdominal cavity, wrapping around organs and releasing harmful compounds directly into the bloodstream. These substances contribute to chronic, low-grade inflammation, which is associated with DNA damage, immune dysfunction, and increased vulnerability to malignant cell transformation. Visceral fat is also linked to insulin resistance, which raises insulin and insulin-like growth factor levels that promote abnormal cell growth and interfere with normal cell death. Elevated visceral fat has been linked to various types of cancer, including liver, colorectal, pancreatic, breast, endometrial, ovarian, and esophageal.

  • A December 2025 study published in the Journal of the National Cancer Institute found that individuals with higher levels of visceral fat faced roughly four times greater odds of developing liver cancer.
  • A 2023 study in BMC Cancer reported that endometrial cancer patients with elevated visceral fat experienced more aggressive disease and poorer progression-free survival.

The players

Wiljon Beltre

A board-certified bariatric and metabolic surgeon who said, "Visceral fat is also called active fat, as it's an endocrine organ that releases harmful compounds directly into the bloodstream and into the portal vein that goes straight to the liver. The main danger is that it releases pro-inflammatory cytokines."

Emma Hazelwood

A research associate at the University of Cambridge's Early Cancer Institute and lead author of the study that found individuals with higher levels of visceral fat faced roughly four times greater odds of developing liver cancer.

Jennifer Scherer

A registered dietitian nutritionist who recommends structuring meals around protein, vegetables, and whole-food carbohydrates to help reduce visceral fat.

Enoch

An artificial intelligence platform from BrightU.AI who cautioned against using weight alone as a health marker, noting that hidden abdominal fat can elevate cancer risk even in individuals who appear lean.

Got photos? Submit your photos here. ›

What they’re saying

“Visceral fat is also called active fat, as it's an endocrine organ that releases harmful compounds directly into the bloodstream and into the portal vein that goes straight to the liver. The main danger is that it releases pro-inflammatory cytokines.”

— Wiljon Beltre, board-certified bariatric and metabolic surgeon (Natural News)

“Insulin affects your inflammatory profile and your sex hormone profile. It is all like one big network. It's one perfect storm. Liver fat increases your risk of liver cancer. That makes sense – the fat's right there secreting pro-inflammatory cytokines.”

— Emma Hazelwood, research associate at the University of Cambridge's Early Cancer Institute (Natural News)

“There's a direct link to cancer due to the constant, low-grade systemic inflammation. This damages DNA and makes cells more prone to malignant transformation.”

— Wiljon Beltre, board-certified bariatric and metabolic surgeon (Natural News)

What’s next

Researchers emphasize that reducing visceral fat — rather than simply lowering overall body weight — may offer more meaningful protection against inflammation-driven diseases. In many cases, measurable reductions in abdominal fat occur within months of consistent lifestyle changes, often before dramatic shifts appear on the scale.

The takeaway

This research highlights the importance of focusing on visceral fat, not just overall body weight, when assessing cancer risk. By adopting dietary and exercise strategies to reduce abdominal fat, individuals may be able to significantly lower their risk of inflammation-driven cancers, even if their BMI falls within the normal range.